Time to telemedicine diagnosis was found to be a useful parameter in assessing the effectiveness of telemedicine in patients who have experienced myocardial infarction.
The Food and Drug Administration approved the 50cc temporary Total Artificial Heart System developed and manufactured by SynCardia Systems, LLC as a bridge to heart transplant for patients who are at imminent risk for death from biventricular failure.
The performance of a European Society of Cardiology algorithm in ruling out acute myocardial infarction without ST-elevation was comparable in patients with and without diabetes mellitus.
For patients with heart failure discharged to a skilled nursing facility and then home, the risk for readmission is highest during the first 2 days at home and is attenuated with a longer SNF length of stay.
Approximately 50% of deaths in people with type 2 diabetes worldwide, and approximately two-thirds of deaths in people with type 2 diabetes in the US are caused by cardiovascular disease.
A literature review revealed that the use of care navigators in conjunction with follow-up telephone calls from nursing staff improved transition of care and readmission rates in patients with congestive heart failure.
Racial differences persist in statin use among adults, specifically African American adults, who are less likely to be treated with any statin or guideline-recommended statin intensity compared with white adults.
